Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom. - Samyshkin Y; Kotchie RW; Mörk AC; Briggs AH; Bateman ED (The European journal of health economics : HEPAC : health economics in prevention and care, 2014)